Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 54
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s...
Sex and Psychedelics: Healing Through Altered States
Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry
Psychedelic Investor Survey Q3 2024
Dispatch From the DEA: DOI and DOC on Trial As Scientists...
Pα+ Psychedelic Bulletin #180: Mass. Psychedelics Ballot Post-Mortem Begins; Cybin Commences...
From Individualism to Connection: How Psychedelics and Group Therapy Can Heal...
Tripping Over Trump: Will the New Administration Embrace Psychedelic Exceptionalism or...
NEW REPORT: Psychedelics at Work – Mapping the Path of the...
How Safe is Ibogaine Therapy? The Delicate Balance of Risk and...
Load more
